Home › NDC Lookup › RxCUI directory › RxCUI 2362240

Capmatinib 150 MG Oral Tablet [Tabrecta] — RxCUI 2362240

RxNorm drug concept · Semantic branded drug
RxCUI 2362240 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2362240
Official nameCapmatinib 150 MG Oral Tablet [Tabrecta]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asTabrecta 150 MG Oral Tablet; Tabrecta 150 MG (as capmatinib HCl 176.55 MG) Oral Tablet
FDA products mapped2
Package NDCs mapped4
Reported Medicaid activity (SDUD)72 prescriptions · 2 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Capmatinib: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Tabrecta is used to treat a specific type of lung cancer — metastatic non-small cell lung cancer — in adults whose tumors have a particular genetic change called a MET exon 14 skip...
  • What exactly is Tabrecta for, and how do I know if it's right for me?
  • You take Tabrecta as a tablet by mouth twice a day — morning and evening works well for most people. You can take it with or without food, which makes it flexible. The important th...
  • How do I take Tabrecta, and what if I miss a dose?
📖 Read our full Capmatinib guide →

🕸️ Concept Web — How Capmatinib 150 MG Oral Tablet [Tabrecta] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Capmatinib 150 MG Oral Tablet [Tabrecta] RxCUI 2362240

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Capmatinib 2362165
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Tabrecta 2362235
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Capmatinib Oral Tablet 2362233
    • Capmatinib Oral Product 2362231
    • Capmatinib Pill 2362232
    • Capmatinib Oral Tablet [Tabrecta] 2362237
    • Tabrecta Oral Product 2362238
    • Tabrecta Pill 2362239
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Capmatinib 150 MG Oral Tablet SCD · 2362234
  • Capmatinib 150 MG SCDC · 2362230
  • Capmatinib Oral Tablet SCDF · 2362233
  • Capmatinib Oral Product SCDG · 2362231
  • Capmatinib Pill SCDG · 2362232

Brand-Name Concepts

  • Capmatinib 150 MG [Tabrecta] SBDC · 2362236
  • Capmatinib Oral Tablet [Tabrecta] SBDF · 2362237
  • Tabrecta Oral Product SBDG · 2362238
  • Tabrecta Pill SBDG · 2362239
  • Tabrecta BN · 2362235

📦 FDA Products & Package NDCs

2 products · 4 package NDCs
4 package NDCs map to RxCUI 2362240 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00078-0709-56 56 TABLET, FILM COATED in 1 BOTTLE (0078-0709-56) TABRECTA Novartis Pharmaceuticals Corporation 2020-05-06
00078-0709-94 56 TABLET, FILM COATED in 1 BOTTLE (0078-0709-94) TABRECTA Novartis Pharmaceuticals Corporation 2020-05-06
00078-0716-56 56 TABLET, FILM COATED in 1 BOTTLE (0078-0716-56) TABRECTA Novartis Pharmaceuticals Corporation 2020-05-06
00078-0716-94 56 TABLET, FILM COATED in 1 BOTTLE (0078-0716-94) TABRECTA Novartis Pharmaceuticals Corporation 2020-05-06
Observed labelers: Novartis Pharmaceuticals Corporation (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.